Status:

COMPLETED

PAS in Subacute SCI

Lead Sponsor:

Helsinki University Central Hospital

Conditions:

Spinal Cord Injuries

Spinal Cord Diseases

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

The investigators have recently shown in incomplete SCI patients that long-term paired associative stimulation is capable of restoring voluntary control over some paralyzed muscles and enhancing motor...

Eligibility Criteria

Inclusion

  • SCI caused by an external trauma or SCI caused by nontraumatic non-progressive disease of the spinal cord
  • Cervical level injury, tetraplegia
  • Time from injury/onset of symptoms 1-4 months
  • Medical condition stable
  • Residual neural connectivity in upper extremity: some voluntary activity in finger muscles or MEPs obtainable from distal hand muscles

Exclusion

  • Diagnosed brain damage, visible in MRI or CT.
  • No activity in hands/fingers and no MEPs recorded from distal hand muscles.
  • Epilepsy
  • Metal inclusion in the head area
  • High intracranial pressure
  • Pacemaker
  • Implanted hearing device
  • Progressive diseases of spinal cord or brain (e.g. malignant tumors, degenerative diseases).
  • History of malignant tumor within the past 5 years.
  • Previous head or spinal cord injury affecting the motor performance of upper extremities.
  • Congenital anomaly in the anatomical structure of spinal canal/cord or dura.
  • Significant systemic disease or other condition that could cause neurological deficit, or may affect subject's capability to undergo investigation-related procedures.
  • Acute severe infection.
  • Contraindications for MRI.
  • Current severe psychiatric diseases.
  • Current chronic drug and/or alcohol abuse.
  • Pregnancy.
  • Severe emergency care polyneuropathy
  • Pressure ulcer affecting the subject's capability to undergo the procedure safely

Key Trial Info

Start Date :

October 10 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 13 2025

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT04101916

Start Date

October 10 2019

End Date

January 13 2025

Last Update

March 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

BioMag laboratory, Helsinki University Central Hospital

Helsinki, Uusimaa, Finland, 00029